Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.81 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.81 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.81 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.81 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.81 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.50 |
| ▸ | PPARG | P37231 | 7/20 | 0.50 |
| ▸ | PPARD | Q03181 | 7/20 | 0.50 |
| ▸ | PPARA | Q07869 | 7/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL3281949 | 1.00 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL273910 | 1.00 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL1515937 | 1.00 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL28265205 | 0.97 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL27826311 | 0.97 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL31032327 | 0.94 | FFAR3 (0.72) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL29707585 | 0.94 | FFAR3 (0.72) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL181441 | 0.94 | FFAR3 (0.72) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL181423 | 0.94 | FFAR3 (0.72) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL14698052 | 0.94 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 494 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113980252-B | Continuous production method of modified poly (butylene succinate) | 上海师范大学 | 2023-09-01 | — | — | CN | claimed |
| CN-113980252-A | Continuous production method of modified poly (butylene succinate) | 上海师范大学 | 2022-01-28 | — | — | CN | claimed |
| CN-113527765-A | Polylactic acid composition and additive composition thereof, plastic product and preparation method thereof | 浙江兴越材料技术有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-111892874-A | Double decomposition unsaturated polyol ester primer and preparation method thereof | 安徽江锐新材料有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-101914299-A | Flame retardant, flame-retarded resin compositions, and process for production of the flame retardant | SONY CORP | 2010-12-15 | — | — | CN | claimed |
| CN-101851399-A | Halogen-free flame retardant polyester product and preparation method thereof | SHANDONG XINGQIANG TECHNOLOGY CO LTD | 2010-10-06 | — | — | CN | claimed |
| US-7781506-B2 | Poly(vinyl alcohol) composition comprising a polyol | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-24 | — | — | US | claimed |
| US-20080182937-A1 | Poly(vinyl alcohol) composition comprising polyol | KURARAY CO., LTD. (JP) | 2008-07-31 | — | — | US | claimed |
| CN-1957037-A | Flame retardant, flame-retardant resin composition and method for producing the flame retardant | SONY CORP (JP) | 2007-05-02 | — | — | CN | claimed |
| EP-3076946-B1 | COMPOSITIONS COMPRISING ANTIOXIDANT, FLUID DISPENSERS, AND METHODS INVOLVING THE SAME | ALZET LLC (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-4633581-A1 | A TOPICAL COMPOSITION | Rock & Herb Pte Ltd (SG) | 2025-10-22 | — | — | EP | disclosed |
| EP-4549055-A1 | INK COMPOSITION | Daicel Corporation (JP) | 2025-05-07 | — | — | EP | disclosed |
| US-20250127776-A1 | ORAL PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-04-24 | — | — | US | disclosed |
| US-20250057835-A1 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-02-20 | — | — | US | disclosed |
| US-4021311-A | Recovery of alkylene glycols by azeotropic distillation with 1,2,3-trimethyl benzene | HALCON INTERNATIONAL, INC. (US) | 1977-05-03 | — | — | US | disclosed |
| US-4008719-A | Osmotic system having laminar arrangement for programming delivery of active agent | ALZA CORPORATION (US) | 1977-02-22 | — | — | US | disclosed |
| US-3997613-A | PLASTICIZER | REICHHOLD CHEMICALS, INC. (US) | 1976-12-14 | — | — | US | disclosed |
| US-3997614-A | ANTIOXIDANT | REICHHOLD CHEMICALS, INC. (US) | 1976-12-14 | — | — | US | disclosed |
| US-3968174-A | MULTISTAGE | HALCON INTERNATIONAL, INC. (US) | 1976-07-06 | — | — | US | disclosed |
| US-3968175-A | ALKENEDIOLS FROM THE DIOL MONOESTER, MULTISTAGE | HALCON INTERNATIONAL, INC. (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127776-A1 | ORAL PHARMACEUTICAL COMPOSITION | LIPA, CYP2C19, PNLIP | FFAR3 1639/4885HDAC3 2674/4885HDAC1 2213/4885 |
| US-20250057835-A1 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND | CYP2C19, CYP2C18, CYP3A7 | FFAR3 2306/4885HDAC3 500/4885HDAC1 468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.